LegoChem Biosciences Inc - Asset Resilience Ratio

Latest as of March 2026: 55.88%

LegoChem Biosciences Inc (141080) has an Asset Resilience Ratio of 55.88% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of LegoChem Biosciences Inc to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩364.86 Billion
≈ $247.26 Million USD Cash + Short-term Investments

Total Assets

₩652.93 Billion
≈ $442.48 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how LegoChem Biosciences Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is LegoChem Biosciences Inc's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down LegoChem Biosciences Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 141080 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩364.86 Billion 55.88%
Total Liquid Assets ₩364.86 Billion 55.88%

Asset Resilience Insights

  • Very High Liquidity: LegoChem Biosciences Inc maintains exceptional liquid asset reserves at 55.88% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

LegoChem Biosciences Inc Industry Peers by Asset Resilience Ratio

Compare LegoChem Biosciences Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Abivax SA
PA:ABVX
Biotechnology 2.58%
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
Biotechnology 2.03%
Neuren Pharmaceuticals Ltd
AU:NEU
Biotechnology 90.43%
Lifecome Biochemistry Co Ltd
SHE:002868
Biotechnology 4.69%
Pulike Biological Engineering
SHG:603566
Biotechnology 17.82%
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Biotechnology 14.00%
NEWRON PHARMACEUT. EO-20
XETRA:NP5
Biotechnology 41.67%
Upstream Bio, Inc.
NASDAQ:UPB
Biotechnology 64.70%

Annual Asset Resilience Ratio for LegoChem Biosciences Inc (2014–2025)

The table below shows the annual Asset Resilience Ratio data for LegoChem Biosciences Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 53.56% ₩375.90 Billion
≈ $254.74 Million
₩701.81 Billion
≈ $475.61 Million
+4.12pp
2024-12-31 49.44% ₩365.04 Billion
≈ $247.38 Million
₩738.38 Billion
≈ $500.39 Million
+21.79pp
2023-12-31 27.65% ₩52.40 Billion
≈ $35.51 Million
₩189.50 Billion
≈ $128.42 Million
+2.95pp
2022-12-31 24.71% ₩62.39 Billion
≈ $42.28 Million
₩252.53 Billion
≈ $171.14 Million
+4.11pp
2021-12-31 20.60% ₩60.39 Billion
≈ $40.93 Million
₩293.23 Billion
≈ $198.72 Million
-17.10pp
2020-12-31 37.70% ₩51.24 Billion
≈ $34.72 Million
₩135.91 Billion
≈ $92.11 Million
+4.45pp
2019-12-31 33.25% ₩47.03 Billion
≈ $31.87 Million
₩141.48 Billion
≈ $95.88 Million
-18.23pp
2018-12-31 51.48% ₩62.64 Billion
≈ $42.45 Million
₩121.69 Billion
≈ $82.47 Million
+25.31pp
2017-12-31 26.17% ₩21.52 Billion
≈ $14.58 Million
₩82.24 Billion
≈ $55.73 Million
-9.70pp
2016-12-31 35.87% ₩32.12 Billion
≈ $21.77 Million
₩89.55 Billion
≈ $60.69 Million
+11.53pp
2015-12-31 24.34% ₩16.66 Billion
≈ $11.29 Million
₩68.44 Billion
≈ $46.38 Million
-59.82pp
2014-12-31 84.16% ₩28.41 Billion
≈ $19.25 Million
₩33.76 Billion
≈ $22.88 Million
--
pp = percentage points

About LegoChem Biosciences Inc

KQ:141080 Korea Biotechnology
Market Cap
$1.98 Billion
₩2.92 Trillion KRW
Market Cap Rank
#6263 Global
#147 in Korea
Share Price
₩80200.00
Change (1 day)
-2.08%
52-Week Range
₩77900.00 - ₩213500.00
All Time High
₩213500.00
About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical devic… Read more